Washington – A pediatric vaccine for respiratory syncytial virus (RSV),a highly contagious, common respiratory virus that infects the nose, throat, and lungs, is on hold, per US Food and Drug Administration`s instructions. An FDA document shows that a phase 1 trial of two experimental Moderna RSV vaccines in infants aged five to eight months was paused in July as five …
Ontario – Through Your Health: A Plan for Connected and Convenient Care, the Ontario government is providing people with the tools they need to stay safe and healthy throughout respiratory illness season. The risk of severe outcomes from RSV infection is highest among those over the age of 60, infants under six months of age and children under 24 months of age …
Ontario – With cooler weather coming in, Toronto Public Health (TPH) encourages eligible residents to get immunized against respiratory infections that include COVID-19, influenza (flu) and Respiratory Syncytial Virus (RSV). Initial doses of the updated COVID-19 (KP.2) vaccine are now available for eligible individuals who are at an increased risk of SARS-CoV-2 infection or severe illness due to COVID-19. Eligible …
Ottawa – Health officials in Canada have changed the guidelines for respiratory syncytial virus vaccines. The National Advisory Committee on Immunization (NACI) now recommends RSV vaccines for individuals who are 75 and older, especially those who have a greater risk of developing severe RSV. Based on current evidence and expert opinion, NACI said in a news release, it also strongly …
Washington – The CDC updated its recommendation for the use of Respiratory Syncytial Virus (RSV) vaccines in people ages 60 and older. For this upcoming respiratory virus season, CDC recommends: Everyone ages 75 and older receive the RSV vaccine. People ages 60–74 who are at increased risk of severe RSV, meaning they have certain chronic medical conditions, such as lung …
Ottawa – Health Canada has approved a new vaccine to protect two groups most severely affected by the respiratory syncytial virus (RSV): newborns, who would receive antibodies through maternal immunization, and Canadians over 60. Pfizer Canada’s bivalent vaccine, called Abrysvo, aims to prevent lower respiratory tract disease caused by the virus. It is the first RSV vaccine in Canada approved …
Toronto – Mayor Olivia Chow proclaimed November 10 as Immunization Day in Toronto. Every year on November 10, World Immunization Day is dedicated to highlighting the effectiveness of vaccines and promoting their use to safeguard against vaccine-preventable diseases. This day underscores the pivotal role of immunization in protecting the health of individuals and communities. The Mayor’s Immunization Day proclamation is …
Current recommendations An updated Covid-19 vaccine has been approved by Health Canada and will be available for use. Covid-19 vaccination reduces the risk of severe illness, death and post Covid-19 condition (long Covid). Starting in fall 2023, it’s recommended that you get an updated Covid-19 vaccine dose if it’s been at least 6 months: since your last Covid-19 vaccine dose …
Ottawa – Health Canada has approved the first vaccine for respiratory syncytial virus (RSV) for adults age 60 and over. Manufacturer GSK says the federal agency has approved its new vaccine called Arexvy. Doctors have been calling for an RSV vaccine for seniors because although the virus is common, older people are much more likely to become severely ill and …
London – AstraZeneca and Sanofi’s Beyfortus (nirsevimab) has been approved in the US for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD) in newborns and infants born during or entering their first RSV season, and for children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season. Beyfortus will be available …
